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The Emerging Role of Urease as a General Microbial
Virulence Factor
Julian C. Rutherford*
Institute for Cell and Molecular Biosciences, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom
Urea is generated in humans following the breakdown of amino
acids and is evenly distributed throughout the body, including in
the central nervous system, subcutaneous adipose tissue, blood
serum, and epithelial lining fluid [1,2]. Various pathogenic
microbes are able to utilise urea as a nitrogen source through
the activity of the enzyme urease that converts urea into ammonia
and carbamic acid, with the spontaneous hydrolysis of carbamic
acid to carbonic acid generating a further ammonia molecule.
CH4N2O+H2ORNH3+CH3NO2
CH3NO2+H2ORNH3+H2CO3
Under physiological conditions the proton of carbonic acid
dissociates, and the ammonia molecules become protonated to
form ammonium, causing an increase in local pH that can
interfere with host function. The role of urease in the virulence of
some bacterial pathogens is well established; however, more recent
studies are beginning to highlight the function of urease during
human fungal infections, suggesting that this enzyme has a wide
role during microbial infection.
Established Roles for Urease during Microbial
Infection
Urease activity is the basis of acid acclimation that enables
Helicobacter pylori to colonise the acidic environment of the human
stomach. In response to the acidification of the periplasm of H.
pylori, a proton gated urea channel (UreI) imports urea into the
bacterial cytosol, where it is hydrolysed by urease [3]. Ammonia
and bicarbonate (following the conversion of carbonic acid to
bicarbonate) are then utilised to buffer protons within the
periplasm [4]. Without this mechanism, H. pylori is unable to
establish infection in the stomach [5,6]. The urease-derived
ammonia is also toxic to host epithelial cells, resulting in cell
damage at the sites of H. pylori infection [7].
A distinct urease-dependent process is associated with bacterial
urinary tract infections, including those caused by Proteus and
Klebsiella species. Infection by these urease-positive bacteria can
result in the development of infection stones that surround and
protect the pathogen. Stones form due to the precipitation of the
minerals struvite and carbonate apatite, which are produced by
the binding of ammonium to magnesium ions and bicarbonate to
calcium ions, respectively [8,9]. As with H. pylori infection in the
stomach, ammonia has an additional role in urinary tract
infections by causing damage to the glycosaminoglycan surface
of the urothelium that protects epithelial cells from bacterial
infection [10,11]. Therefore, urease-mediated pH changes and
damage to host epithelial cells are associated with the promotion of
some bacterial infections.
Emerging Pathogenic Roles for Urease during
Fungal Infections
Studies of two evolutionarily diverse fungi, Cryptococcus neoformans
(a basidiomycete) and Coccidioides posadasii (an ascomycete), suggest
that urease has conserved roles in promoting bacterial and fungal
infections. The inhalation and subsequent germination of fungal
spores is the route of entry into the body for many fungal
pathogens. Successful infection of the lung requires the pathogen
to evade the host immune system, and subsequent dissemination is
dependent on the ability of the fungus to move from the lungs to
other organs via the bloodstream. C. neoformans and Co. posadasii are
saprophytic yeast that infect humans via the lungs and cause
disease, with the severity of infection correlating with a loss of host
immune function, and in both cases, the disseminated form of
infection is potentially life threatening [12,13]. Studies of both C.
neoformans and Co. posadasii suggest that urease-dependent pH
changes are involved in immune system evasion and that ammonia
toxicity to host cells promotes systemic disease.
Urease is required for the full virulence of C. neoformans and Co.
posadasii in animal models of disease [14,15]. Urease-positive
strains of both yeasts promote host responses that are consistent
with a nonprotective Type 2 (Th2) rather than a fungicidal Type 1
(Th1) immune response [15,16]. Consequently, mice infected with
urease-positive C. neoformans have higher levels of serum IgE, Th2
cytokines, and alternatively activated macrophages as compared to
control mice infected with a urease-negative strain [16]. Further-
more, a Th2 host response may also provide the pathogen with
additional host-derived urea as alternatively activated macrophag-
es convert arginine to ornithine and urea [17]. The detection of
urease-dependent increases in arginase expression and higher
levels of urea at sites of Co. posadasii infection support this positive
feedback model [15,16].
One mechanism to account for the urease-dependent Th2
polarisation of the host immune system is that the pH changes
associated with urease activity cause a reduction in the acidifica-
tion and maturation of phagolysosomes in phagocytic cells,
resulting in a loss of pathogen killing and antigen presentation.
A range of studies are consistent with this model. Fungi excrete
ammonia as part of their internal pH control, and localised
increases in pH are associated with Co. posadasii infection [15].
Ammonia prevents phagosome and lysosomal fusion and matu-
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ration in mouse peritoneal macrophages [18]. Immature dendritic
cells promote Th2 polarisation, and higher levels of this class of
antigen-presenting cells are found in mice infected with urease-
positive rather than urease-negative C. neoformans [16]. Consistent
with these findings are bacterial studies of urease-deficient
Mycobacterium bovis, which localise more efficiently with lysosomes
than a parental wild-type strain [19]. Furthermore, M. bovis-
derived ammonia accumulates in macrophages and correlates with
the reduction in the cell surface trafficking of the major
histocompatibility complex class II [20].
The dissemination of a fungal pathogen from the lungs to other
organs will be facilitated by damage to epithelial cells that allow
pathogen access to and from the bloodstream. Ammonia is toxic to
mammalian cells, and the urease-dependent damage to human
epithelial cells by bacterial pathogens suggests that the ammonia
produced by urease-positive fungi may also promote fungal
dispersal [7,10,11,21]. Evidence to support this comes from two
studies involving C. neoformans. Urease activity negatively influences
the integrity of endothelial junctions in vitro, as assayed using
human brain microvascular endothelial cells [22]. Urease also
promotes the crossing of C. neoformans across the blood-brain
barrier in vivo after the pathogen becomes trapped in the small
capillaries of the mouse brain [23]. Therefore, a plausible model is
that circulating host urea is metabolised by yeast trapped in the
small capillaries of the brain, resulting in the export of ammonia.
The localised death of host epithelium cells then results in a loss of
integrity of the blood-brain barrier, allowing C. neoformans to
migrate into the brain parenchyma. A prediction is that pathogen-
derived ammonia has the potential to kill host cells throughout the
body.
The studies relating to the ammonia repression of phagocyte
function and localised tissue damage suggest a general model for
the role of urease during fungal infections (Figure 1). Initially
inhaled fungal spores germinate and fungal cells are able to
proliferate in imunocompromised individuals due to a reduction in
host immune function. Metabolism of host-derived urea results in
the excretion of ammonia from fungal cells, which contributes to
host tissue damage and further inhibition of the host immune
system by repressing phagocyte function. Fungal cell access to the
bloodstream is facilitated by damage to lung tissue allowing
distribution of fungal cells throughout the body, which become
trapped in small capillary beds. Urease-dependent ammonia
secretion then causes damage to capillary epithelial cells, enabling
fungal cells to traverse from the bloodstream into organs where
continued urease activity promotes infection.
Urease as a Therapeutic Target
Urease was the first protein to be identified as a nickel enzyme
[24]. Humans do not contain urease, and no human nickel
enzymes are known, making urease a potential therapeutic target.
Notably, the maturation of urease is a complex process involving a
Figure 1. Model of urease function during fungal infection via the lungs. Following the inhalation of spores, yeasts germinate in the lungs. If
the initial infection is not cleared due to a defective host immune response, yeast cells proliferate. Urea is present in the epithelial lining fluid of the
lungs, and the urease-dependent secretion of ammonia from yeast cells further inhibits immune function by impairing phagocyte function and
contributes to lung tissue damage. Individual yeast cells gain access to the bloodstream in damaged areas and circulate in the body until becoming
trapped in small capillary beds. Circulating urea is then metabolised by the trapped yeast, resulting in ammonia secretion and damage to the
epithelial cells of the capillary beds, enabling yeast cells to cross and proliferate in host organs.
doi:10.1371/journal.ppat.1004062.g001
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number of accessory proteins that are involved in the delivery and
insertion of nickel into the active site of the enzyme, which
contains two nickel atoms bridged by a carbamylated lysine
residue. An impressive range of in vivo and in vitro studies of
urease maturation in different bacteria, including H. pylori,
Sporosarcina pasteurii, and Klebsiella aerogenes, have culminated in
the following model of urease activation [25,26]. Urease initially
folds in an apo-form to which a complex of three additional
accessory proteins (UreD, UreF, and UreG) binds. UreG is a
GTPase that forms a dimer and contains a nickel-binding site at its
dimer interface. The accessory protein complex increases exposure
of the apo-active site, resulting in carbamylation of the active site
lysine and nickel insertion by a process that requires carbon
dioxide and GTP hydrolysis. Nickel is delivered to UreG by the
nickel-binding chaperone UreE, which acquires the metal from an
imported pool of nickel. It is presently not clear if UreE delivers
nickel to the accessory protein complex before or after it binds to
apo-urease. Once the active enzyme is formed, the accessory
protein complex dissociates.
The bacterial mechanism of urease maturation is predicted to
occur in fungal cells. Homologues of the bacterial UreDFG
proteins (Ure467) and a nickel importer (Nic1) exist in C. neoformans
and are essential for full urease activity [22]. It appears that fungi
lack a nickel chaperone with the Ure7 GTPase potentially having
a dual GTPase/nickel chaperone role, as it contains a histidine-
rich nickel-binding domain [22]. As with other metal chaperones,
an intriguing question is where in the cell Ure7 initially binds
nickel and whether this involves a direct interaction with the Nic1
nickel importer. The complexity of urease maturation therefore
suggests that this pathway is a potential target for chemical
intervention, in addition to the development of inhibitors of the
mature enzyme, including nickel chelators and substrate analogues
[27].
Perspectives
The model of urease function during fungal infections is based
on studies of two pathogenic fungi and the extrapolation of work
with bacterial pathogens. However, nothing is known about the
role of this enzyme during infection by other urease-positive fungi
that infect the lungs, such as Aspergillus fumigatus, Histoplasma
capsulatum, Blastomyces dermatitidis, and Paracoccidioides brasiliensis
[28,29]. It would also be interesting to determine why some but
not all dermatophyte species that cause skin infections are urease
positive [30]. Future work needs to address whether and to what
extent urease is required for the virulence of these organisms, and
if it is required, whether this simply relates to the provision of a
nitrogen source for the pathogen or involves more complex pH-
mediated damage to host cells and immunity. Potentially, such
studies will enable similar strategies to be developed to treat a wide
range of disparate bacterial and fungal infections.
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